A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500).

A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500).

The aim of the reported trial was to investigate the safety and efficacy of memantine in mild to moderate vascular dementia (VaD). This was a 28-week, double-blind, parallel, randomized controlled trial of memantine 20 mg daily versus placebo which was conducted in 54 centres in the UK. Memantine is...

Detaylı Bibliyografya
Asıl Yazarlar:	Wilcock, G, Möbius, H, Stöffler, A
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2002

Benzer Materyaller

Memantine for the treatment of dementia.
Yazar:: Wilcock, G
Baskı/Yayın Bilgisi: (2003)

Memantine for dementia.
Yazar:: Mcshane, R, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial.
Yazar:: Hanney, M, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Multicentre randomised double-blinded placebo-controlled trial of favipiravir in adults with mild COVID-19
Yazar:: Majed Al-Jeraisy, ve diğerleri
Baskı/Yayın Bilgisi: (2021-04-01)

A Randomized, Double-blind, Placebo-Controlled Study of Latrepirdine in Patients With Mild to Moderate Huntington Disease
Yazar:: Kieburtz, K, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Low-dose naltrexone for the induction of remission in patients with mild to moderate Crohn’s disease: protocol for the randomised, double-blinded, placebo-controlled, multicentre LDN Crohn study
Yazar:: Christien Janneke van der Woude, ve diğerleri
Baskı/Yayın Bilgisi: (2022-04-01)

EFFICACY AND TOLERABILITY OF LERCANIDIPINE IN ELDERLY PATIENTS WITH MILD TO MODERATE HYPERTENSION IN A PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY
Yazar:: M. A. Ninci, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT.
Yazar:: Jones, R, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Leritrelvir for the treatment of mild or moderate COVID-19 without co-administered ritonavir: a multicentre randomised, double-blind, placebo-controlled phase 3 trialResearch in context
Yazar:: Yangqing Zhan, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Effectiveness of ayurvedic formulation, NAOQ19 along with standard care in the treatment of mild-moderate COVID-19 patients: A double blind, randomized, placebo-controlled, multicentric trial
Yazar:: Pankaj Bhardwaj, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01)

Efficacy and safety of butylphthalide in patients with mild cognitive impairment: a multicentre, randomised, double-blind, placebo-controlled trial (EBMCI study)
Yazar:: Pin Wang, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01)

Galantamine-Memantine Combination in the Treatment of Parkinson’s Disease Dementia
Yazar:: Emma D. Frost, ve diğerleri
Baskı/Yayın Bilgisi: (2024-11-01)

Tetrodotoxin for Moderate to Severe Cancer-Related Pain: A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Trial
Yazar:: Neil A. Hagen, ve diğerleri
Baskı/Yayın Bilgisi: (2017-01-01)

MMM in the finance-growth nexus
Yazar:: Achmad Tohirin, ve diğerleri
Baskı/Yayın Bilgisi: (2011-11-01)

Lack of evidence for the efficacy of memantine in mild Alzheimer disease
Yazar:: Schneider, L, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Lack of evidence for the efficacy of memantine in mild Alzheimer disease.
Yazar:: Schneider, L, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Treatment benefits of memantine in moderately severe to severe Alzheimer's disease patients with behavioural symptoms
Yazar:: Wilcock, G, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study.
Yazar:: Tohen, M, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Donepezil and memantine for moderate-to-severe Alzheimer's disease
Yazar:: Howard, R, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Vascular dementia.
Yazar:: Amar, K, ve diğerleri
Baskı/Yayın Bilgisi: (1995)

Vascular dementia.
Yazar:: Amar, K, ve diğerleri
Baskı/Yayın Bilgisi: (1996)

The pharmacological treatment of Alzheimer's disease with cholinesterase inhibitors and memantine
Yazar:: Wilcock, G
Baskı/Yayın Bilgisi: (2007)

The clinical use of memantine
Yazar:: Burns, A, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.
Yazar:: Pavord, I, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Randomised Double-blind Placebo-Controlled Multicentre Trial for the Effects of Yokukansan in Smokers with Depressive Tendencies
Yazar:: Maki Komiyama, ve diğerleri
Baskı/Yayın Bilgisi: (2023-04-01)

Multicentre Double-Blind Placebo-Controlled Food Challenge Study in Children Sensitised to Cashew Nut.
Yazar:: Johanna P M van der Valk, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

Flurizan, (MPC-7869, (R)-flurbiprofen) a selective A beta-42 lowering agent in patients with mild to moderate Alzheimer's disease: A randomised, placebo-controlled, double blind trial
Yazar:: Wilcock, G, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India
Yazar:: Ravikirti, ve diğerleri
Baskı/Yayın Bilgisi: (2021-07-01)

A randomized double-blind placebo-controlled trial of an inhibitor of plasminogen activator inhibitor-1 (TM5614) in mild to moderate COVID-19
Yazar:: Toyohiro Hirai, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

A Double-Blind Randomized Placebo-Controlled Withdrawal Trial Comparing Memantine and Antipsychotics for the Long-Term Treatment of Function and Neuropsychiatric Symptoms in People With Alzheimer's Disease (MAIN-AD).
Yazar:: Ballard, C, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies.
Yazar:: Wilcock, G, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Theobromine for the treatment of persistent cough: a randomised, multicentre, double-blind, placebo-controlled clinical trial
Yazar:: Morice, A, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
Yazar:: Wang, Y, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Nitroglycerin for treatment of retained placenta: a randomized, placebo-controlled, multicentre double blind trial in the UK
Yazar:: Denison, F, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Nitroglycerin for treatment of retained placenta: A randomised, placebo-controlled, multicentre, double-blind trial in the UK.
Yazar:: Fiona C Denison, ve diğerleri
Baskı/Yayın Bilgisi: (2019-12-01)

Diagnostic criteria for vascular dementia
Yazar:: Amar, K, ve diğerleri
Baskı/Yayın Bilgisi: (1996)

Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study
Yazar:: A. David Burden, ve diğerleri
Baskı/Yayın Bilgisi: (2023-09-01)

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial
Yazar:: Thwaites, GE, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

How effective is topical miconazole or amorolfine for mild to moderately severe onychomycosis in primary care: the Onycho Trial – a randomised double-blind placebo-controlled trial
Yazar:: Mattijs E Numans, ve diğerleri
Baskı/Yayın Bilgisi: (2024-05-01)

Chinese herbal medicine Shufeng Jiedu capsule for mild to moderate COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase II trial
Yazar:: Chun-li Lu, ve diğerleri
Baskı/Yayın Bilgisi: (2024-05-01)